Sep 15, 2026 earnings call — Seed reconfiguration and cost cuts
Company returned to positive adjusted EBITDA in the quarter, improving from negative $9.6 million to positive $600 thousand.
Revenue $0.1B (est $0.1B) · EPS $-0.39 (est $-0.06)
Key quotes
"Adjusted EBITDA improved by approximately $10 million year over year from negative $9.6 million to positive $600 thousand"
"We have now substantially completed the nearly 2-year reconfiguration of our seed business."
"At Rizobacter, we successfully pursued the reprofiling of approximately $28 million of bank debt obligations and completed a voluntary maturity extension process for our local bond debt in Argentina covering $46.5 million in aggregate principal amount of outstanding notes."